TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production [Yahoo! Finance]
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.
Should You Sell Maravai LifeSciences (MRVI)? [Yahoo! Finance]